RT @_TanyaBondar_: It is time to look at tumor-specific T-cell responses in plasma cell neoplasms. Like T-cell responses to mutant MyD88, a…
It is time to look at tumor-specific T-cell responses in plasma cell neoplasms. Like T-cell responses to mutant MyD88, a driver neoantigen, in WM patients. @MadhavDhodapkar https://t.co/XbmI0CalK5
Reading for #IMS2022 session on immune reconstitution: Two works by @MadhavDhodapkar. https://t.co/1XThqVTPxU https://t.co/HbUQ1Phamx
RT @BCD_AACR: Waldenström's #Macroglobulinemia opens the program of #IMS2022. Relevant article by @MadhavDhodapkar: Origins of WM. https://…
Waldenström's #Macroglobulinemia opens the program of #IMS2022. Relevant article by @MadhavDhodapkar: Origins of WM. https://t.co/3odHCR0HXJ #MMsm https://t.co/t3VAGrF7j5
#ICYMI: Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia by Akhilesh Kaushal, Madhav V. Dhodapkar, and colleagues. https://t.co/5p2vVXgzDT https://t.co/btgKQo4ySI
RT @_TanyaBondar_: @BrunoPaiva_UNAV @ScienceAdvances Very interesting findings, in line with the recently reported MyD88 mutations in prema…
#ICYMI: Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia by Madhav V. Dhodapkar, Akhilesh Kaushal and colleagues. https://t.co/TTgb5SHTIc https://t.co/GemhXUxMDX
@BrunoPaiva_UNAV @ScienceAdvances Very interesting findings, in line with the recently reported MyD88 mutations in premalignant B cells and progenitors in WM: https://t.co/CIXl7p1HJ1
RT @BCD_AACR: In the November issue: Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenito…
In the November issue: Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia. https://t.co/05huoLquai https://t.co/4sb8gy9GgZ
Cool information!
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia https://t.co/8epDhyGJUe
RT @dramatorresvi: Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldens…
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia | Blood Cancer Discovery https://t.co/drKxY01bId
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
Stephen Ansell will present #immunotherapy developments in #DLBCL at #AACRdlbcl. Read his research on interactions b/t malignant B cells & immune microenv: https://t.co/V6niHzLuKW. @MayoClinic #lymsm #lymphoma https://t.co/OrRnSJfEak
RT @MadhavDhodapkar: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malign…
Related article: https://t.co/FTMckFcS3K
RT @MadhavDhodapkar: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malign…
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
RT @MadhavDhodapkar: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malign…
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
RT @BCD_AACR: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in…
Insightful paper on Waldenstrom macroglobulemia cell of origin! 🤯 Congratulation @MadhavDhodapkar and team!
Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in Waldenstrom macroglobulinemia. @WinshipAtEmory @MadhavDhodapkar #singlecell #WMsm #LYMsm #mmsm https://t.co/FTMckFcS3K https://t.c
RT @MadhavDhodapkar: Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malign…
Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation and MyD88-mutant progenitors precede malignancy in Waldenstrom macroglobulinemia https://t.co/yfC6j7oqr3